07:00 , Aug 18, 2003 |  BC Week In Review  |  Company News

Amphioxus Cell Technologies, PerBio Science sales and marketing update

Perbio division Pierce Biotechnology (Rockford, Ill.) and Amphioxus will co-market Pierce's IQ kinase assay technology and Amphioxus' ACTIVTox human liver cell line technology. The products are used in target identification and validation specific to kinases,...
07:00 , Aug 13, 2003 |  BC Extra  |  Company News

Pierce, Amphioxus co-marketing deal

Pierce Biotechnology (Rockford, Ill.) and Amphioxus Cell Technologies (Houston, Texas) will co-market Pierce's IQ kinase assay technology and Amphioxus' ACTIVTox human liver cell line technology. The products are used in target identification and validation specific...
08:00 , Jan 10, 2000 |  BC Week In Review  |  Company News

Amphioxus Cell Technologies, Incyte Pharmaceuticals Inc. deal

Amphioxus, a liver biology company, granted INCY an exclusive access to its C3A cloned human liver cell line, which simulates liver responses to drug and stress stimuli. INCY will use C3A to generate gene expression...